CLDX Stock: Price, Earnings History and SEC Filings
Celldex Therapeutics, Inc. (CLDX) last traded at $30.10, up 0.70% on the latest session and down 7.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.94 against an analyst estimate of $-1.04, a beat of 9.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CLDX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.94 | $-1.04 | +9.62% |
| Mar 2026 | May 7, 2026 | $-1.18 | $-1.10 | -7.27% |
| Dec 2025 | Feb 25, 2026 | $-1.22 | $-1.00 | -22.00% |
| Sep 2025 | Nov 10, 2025 | $-1.01 | $-0.88 | -14.77% |
CLDX beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
CLDX financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2M | -$259M | -$214M | -16748.0% | $-3.90 |
| 2024 | $7M | -$158M | -$160M | -2248.8% | $-2.45 |
| 2023 | $7M | -$141M | -$109M | -2054.8% | $-2.92 |
| 2022 | $2M | – | -$106M | – | $-2.40 |
| 2021 | $5M | – | -$62M | – | $-1.64 |
| 2020 | $7M | – | -$42M | – | $-2.02 |
| 2019 | $4M | – | -$47M | – | $-3.51 |
| 2018 | $10M | – | -$76M | – | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CLDX
SEC filing data is not available right now. You can search for CLDX on SEC EDGAR.
CLDX news
No recent headlines found. The live terminal has the full news feed.
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. (CLDX) is a US-listed public company on Nasdaq.